ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
From diagnosis to daily realities: longitudinal phenomenological exploration of symptom trajectories in glioma survivorship.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith the continuous improvement of global cancer survival rates, the long-term quality of life among cancer survivors has attracted increasing attention. Glioma is a common primary malignant tumor of the central nervous system. Both the disease itself and anti-tumor therapies induce a variety of dynamically fluctuating symptoms throughout the disease course, which impose persistent physical and psychological impairments and substantially compromise patients' quality of life. Current qualitative studies have only preliminarily explored symptom-related issues in patients with glioma, lacking longitudinal analyses regarding the dynamic evolution of patients' symptom perceptions, coping strategies, and care demands. Accordingly, this study adopts a longitudinal phenomenological approach to address the gaps in existing evidence.
aimsThis longitudinal qualitative study aims to conduct a phenomenological exploration of the symptom trajectories in glioma survivorship, specifically focusing on the evolving processes of symptom recognition, the diversity of long-term coping strategies, the clinical challenges in symptom modulation, and the resultant needs for a structured intervention framework.
methodsBased on the phenomenological approach, semi-structured interviews were implemented among 12 glioma survivors at three time points (T1, initial diagnosis; T2, 1 month after surgery; T3, 3 months after surgery). Colaizzi's method was used to analyze interview transcripts and extract the essential themes of patients' long-term survivorship experience.
resultsThe following four themes and associated categories were identified: (1) self-perception and interpretation of the disease, (2) differentiated coping with symptoms, (3) practical dilemmas in symptom management, (4) core needs in symptom management.
conclusionThe symptom journey for glioma survivors is not static but a complex trajectory marked by significant and evolving burdens. Our findings, extending from our earlier research, underscore the critical need for healthcare systems to move beyond episodic care. Future efforts must focus on developing longitudinal, patient-centered intervention frameworks that address the unmet needs across the survivorship continuum, thereby effectively reducing symptom burden and enhancing quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.